Investment House LLC Sells 100 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Investment House LLC cut its position in UnitedHealth Group Incorporated (NYSE:UNH) by 1.1% in the fourth quarter, HoldingsChannel.com reports. The firm owned 9,375 shares of the healthcare conglomerate’s stock after selling 100 shares during the period. Investment House LLC’s holdings in UnitedHealth Group were worth $4,742,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in UNH. NewSquare Capital LLC bought a new position in UnitedHealth Group in the fourth quarter worth about $25,000. AlphaMark Advisors LLC bought a new position in UnitedHealth Group in the fourth quarter worth about $30,000. Promus Capital LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth about $32,000. RPg Family Wealth Advisory LLC purchased a new stake in shares of UnitedHealth Group during the third quarter worth about $37,000. Finally, Pillar Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth about $40,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Up 0.9 %

Shares of NYSE:UNH opened at $503.61 on Wednesday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The firm has a market capitalization of $460.66 billion, a price-to-earnings ratio of 32.49, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The business’s 50 day moving average price is $510.90 and its 200-day moving average price is $548.54.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the firm posted $5.83 EPS. The business’s revenue was up 6.8% on a year-over-year basis. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.67%. UnitedHealth Group’s payout ratio is currently 54.19%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on UNH shares. Cantor Fitzgerald restated an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Wells Fargo & Company dropped their price target on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Piper Sandler cut their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Oppenheimer increased their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Finally, Stephens increased their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Twenty equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $629.32.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The shares were bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.